DENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Upgraded by StockNews.com

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) was upgraded by equities research analysts at StockNews.com from a "hold" rating to a "buy" rating in a research note issued to investors on Tuesday.

Several other equities analysts also recently issued reports on XRAY. UBS Group reduced their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a report on Tuesday, December 3rd. Evercore ISI restated an "in-line" rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Needham & Company LLC restated a "buy" rating and set a $25.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, February 11th. Jefferies Financial Group cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and cut their price objective for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Finally, Wells Fargo & Company began coverage on shares of DENTSPLY SIRONA in a research note on Friday, February 14th. They set an "equal weight" rating and a $20.00 price objective on the stock. Ten analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $25.85.

DENTSPLY SIRONA Trading Down 1.1 %

Shares of DENTSPLY SIRONA stock traded down $0.20 during mid-day trading on Tuesday, hitting $18.75. 1,765,748 shares of the stock were exchanged, compared to its average volume of 2,326,868. DENTSPLY SIRONA has a twelve month low of $17.21 and a twelve month high of $34.91. The stock has a market capitalization of $3.73 billion, a price-to-earnings ratio of -9.06, a price-to-earnings-growth ratio of 1.81 and a beta of 0.96. The company has a 50-day simple moving average of $18.94 and a 200 day simple moving average of $21.75. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

Institutional Investors Weigh In On DENTSPLY SIRONA

Hedge funds have recently modified their holdings of the business. Riverview Trust Co acquired a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth about $26,000. Colonial Trust Co SC bought a new position in shares of DENTSPLY SIRONA during the fourth quarter worth about $26,000. Capital Performance Advisors LLP bought a new position in shares of DENTSPLY SIRONA during the third quarter worth about $27,000. MassMutual Private Wealth & Trust FSB grew its holdings in shares of DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after buying an additional 1,232 shares in the last quarter. Finally, UMB Bank n.a. grew its holdings in shares of DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after buying an additional 564 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.